{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:21:04Z","timestamp":1791404464356,"version":"4.3.3"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571802"],"award-info":[{"award-number":["81571802"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["2015CB931804"],"award-info":[{"award-number":["2015CB931804"]}],"id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2016J06020"],"award-info":[{"award-number":["2016J06020"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.actbio.2018.06.034","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T06:28:37Z","timestamp":1530167317000},"page":"257-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib\/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer"],"prefix":"10.1016","volume":"76","author":[{"given":"Tingting","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2018.06.034_b0005","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.7150\/jca.19867","article-title":"The comparison of EGFR-TKI failure modes and subsequent management between exon 19 deletion and exon 21 L858R mutation in advanced non-small-cell lung cancer","volume":"8","author":"Zhang","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.actbio.2018.06.034_b0010","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1074\/mcp.M117.067439","article-title":"Quantitative tyrosine phosphoproteomics of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor-treated lung adenocarcinoma cells reveals potential novel biomarkers of therapeutic response","volume":"16","author":"Zhang","year":"2017","journal-title":"Mol. Cell. Proteom. MCP"},{"key":"10.1016\/j.actbio.2018.06.034_b0015","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1634\/theoncologist.2011-0087","article-title":"The role of irreversible HER family inhibition in the treatment of patients with non-small cell lung cancer","volume":"16","author":"Kwak","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.actbio.2018.06.034_b0020","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1038\/onc.2008.109","article-title":"BIBW2992, an irreversible EGFR\/HER2 inhibitor highly effective in preclinical lung cancer models","volume":"27","author":"Li","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.actbio.2018.06.034_b0025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1586\/17512433.2015.1055252","article-title":"Strategies to overcome resistance to tyrosine kinase inhibitors in non-small-cell lung cancer","volume":"8","author":"Santarpia","year":"2015","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.actbio.2018.06.034_b0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.canlet.2017.07.023","article-title":"Drug combination approach to overcome resistance to EGFR tyrosine kinase inhibitors in lung cancer","volume":"405","author":"Tong","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.actbio.2018.06.034_b0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3892\/etm.2017.4501","article-title":"Small interfering RNA targeting of the survivin gene inhibits human tumor cell growth in vitro","volume":"14","author":"Zhang","year":"2017","journal-title":"Experiment. Ther. Med."},{"key":"10.1016\/j.actbio.2018.06.034_b0040","first-page":"61","article-title":"Survivin, cancer networks and pathway-directed drug discovery, Nature reviews","volume":"8","author":"Altieri","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.actbio.2018.06.034_b0045","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3892\/ijo_00000464","article-title":"Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma","volume":"35","author":"Krepela","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.actbio.2018.06.034_b0050","doi-asserted-by":"crossref","first-page":"10402","DOI":"10.1158\/0008-5472.CAN-10-2438","article-title":"Role of survivin in EGFR inhibitor-induced apoptosis in non-small cell lung cancers positive for EGFR mutations","volume":"70","author":"Okamoto","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2018.06.034_b0055","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1158\/1535-7163.MCT-11-0638","article-title":"Overcoming erlotinib resistance in EGFR mutation-positive non-small cell lung cancer cells by targeting survivin","volume":"11","author":"Okamoto","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.actbio.2018.06.034_b0060","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12013-014-0445-z","article-title":"Downregulation of Survivin by shRNA inhibits invasion and enhances the radiosensitivity of laryngeal squamous cell carcinoma","volume":"72","author":"Hu","year":"2015","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.actbio.2018.06.034_b0065","first-page":"22053","article-title":"Construction and identification of multiple genes Co silence of plasmid shRNA","volume":"8","author":"Sun","year":"2015","journal-title":"Int. J. Clin. Experiment. Med."},{"key":"10.1016\/j.actbio.2018.06.034_b0070","doi-asserted-by":"crossref","first-page":"7086","DOI":"10.3892\/mmr.2017.7490","article-title":"Transfection with Livin and Survivin shRNA inhibits the growth and proliferation of nonsmall cell lung cancer cells","volume":"16","author":"Huang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.actbio.2018.06.034_b0075","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1021\/mp400576f","article-title":"iRGD conjugated TPGS mediates codelivery of paclitaxel and survivin shRNA for the reversal of lung cancer resistance","volume":"11","author":"Shen","year":"2014","journal-title":"Mol. Pharmaceutics"},{"key":"10.1016\/j.actbio.2018.06.034_b0080","doi-asserted-by":"crossref","first-page":"8613","DOI":"10.1016\/j.biomaterials.2012.08.007","article-title":"Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI\/TPGS complex nanoparticles to overcome drug resistance in lung cancer","volume":"33","author":"Shen","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2018.06.034_b0085","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1359-6446(01)01757-3","article-title":"Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications","volume":"6","author":"Esfand","year":"2001","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.actbio.2018.06.034_b0090","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.biomaterials.2010.09.002","article-title":"PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors","volume":"32","author":"He","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2018.06.034_b0095","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1016\/j.biomaterials.2012.02.004","article-title":"A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas","volume":"33","author":"Li","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2018.06.034_b0100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.msec.2017.02.144","article-title":"Highly water-soluble, pH sensitive and biocompatible PAMAM 'dendrizyme' to maintain catalytic activity in complex medium","volume":"78","author":"Wang","year":"2017","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.actbio.2018.06.034_b0105","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/aa8a3d","article-title":"Nanoparticles target early-stage breast cancer metastasis in vivo","author":"Goldman","year":"2017","journal-title":"Nanotechnology"},{"key":"10.1016\/j.actbio.2018.06.034_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9060069","article-title":"Selection of nucleic acid aptamers targeting tumor cell-surface protein biomarkers","volume":"9","author":"Mercier","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.actbio.2018.06.034_b0115","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/aps.2013.137","article-title":"DNA aptamers that target human glioblastoma multiforme cells overexpressing epidermal growth factor receptor variant III in vitro","volume":"34","author":"Tan","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.actbio.2018.06.034_b0120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biomaterials.2017.08.030","article-title":"Co-delivery of oxygen and erlotinib by aptamer-modified liposomal complexes to reverse hypoxia-induced drug resistance in lung cancer","volume":"145","author":"Li","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2018.06.034_b0125","first-page":"878","article-title":"Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy","volume":"8","author":"Tannock","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2018.06.034_b0130","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jconrel.2016.07.028","article-title":"Accumulating nanoparticles by EPR: A route of no return","volume":"238","author":"Ngoune","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2018.06.034_b0135","first-page":"2804","article-title":"Limited tissue penetration of taxanes: a mechanism for resistance in solid tumors, Clinical cancer research : an official journal of the American Association for","volume":"13","author":"Kyle","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2018.06.034_b0140","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.3892\/mmr.2016.4868","article-title":"Targeting of cancerassociated fibroblasts enhances the efficacy of cancer chemotherapy by regulating the tumor microenvironment","volume":"13","author":"Li","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.actbio.2018.06.034_b0145","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ccell.2016.10.006","article-title":"Inhibition of the glycolytic activator PFKFB3 in endothelium induces tumor vessel normalization, impairs metastasis, and improves chemotherapy","volume":"30","author":"Cantelmo","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.actbio.2018.06.034_b0150","first-page":"65","article-title":"Atorvastatin enhanced nitric oxide release and reduced blood pressure, nitroxidative stress and rantes levels in hypertensive rats with diabetes","volume":"66","author":"Mason","year":"2015","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.actbio.2018.06.034_b0155","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","article-title":"Tumor angiogenesis and vascular normalization: alternative therapeutic targets","volume":"20","author":"Viallard","year":"2017","journal-title":"Angiogenesis"},{"key":"10.1016\/j.actbio.2018.06.034_b0160","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ccr.2014.06.025","article-title":"Tumor vessel normalization by chloroquine independent of autophagy","volume":"26","author":"Maes","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.actbio.2018.06.034_b0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/0008-5472.CAN-12-2464","article-title":"Chloroquine in cancer therapy: a double-edged sword of autophagy","volume":"73","author":"Kimura","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2018.06.034_b0170","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.actbio.2018.06.034_b0175","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.biomaterials.2010.11.001","article-title":"Reversal of multidrug resistance by reduction-sensitive linear cationic click polymer\/iMDR1-pDNA complex nanoparticles","volume":"32","author":"Gao","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2018.06.034_b0180","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2010.12.014","article-title":"Bioreducible poly (\u03b2-amino esters)\/shRNA complex nanoparticles for efficient RNA delivery","volume":"151","author":"Yin","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2018.06.034_b0185","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jemt.20779","article-title":"Green fluorescent protein as indicator of nonviral transient transfection efficiency in endometrial and testicular biopsies","volume":"73","author":"Zizzi","year":"2010","journal-title":"Microsc. Res. Techn."},{"key":"10.1016\/j.actbio.2018.06.034_b0190","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejphar.2015.12.017","article-title":"Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies","volume":"771","author":"Pascolo","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.actbio.2018.06.034_b0195","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1021\/bc700478s","article-title":"Novel thermoresponsive nonviral gene vector: P(NIPAAm-co-NDAPM)-b-PEI with adjustable gene transfection efficiency","volume":"19","author":"Cheng","year":"2008","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.actbio.2018.06.034_b0200","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/CAD.0b013e3283627a0b","article-title":"Chaetoglobosin K inhibits tumor angiogenesis through downregulation of vascular epithelial growth factor-binding hypoxia-inducible factor 1alpha","volume":"24","author":"Luo","year":"2013","journal-title":"Anti-cancer Drugs"},{"key":"10.1016\/j.actbio.2018.06.034_b0205","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jconrel.2008.12.015","article-title":"Cellular uptake of self-assembled cationic peptide-DNA complexes: multifunctional role of the enhancer chloroquine","volume":"135","author":"Yang","year":"2009","journal-title":"J. Controll. Release"},{"key":"10.1016\/j.actbio.2018.06.034_b0210","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2174\/1389450116666141205145620","article-title":"The EGFR pathway regulates BCRP expression in NSCLC cells: role of erlotinib","volume":"15","author":"Porcelli","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.actbio.2018.06.034_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048004","article-title":"Modeling of tumor progression in NSCLC and intrinsic resistance to TKI in loss of PTEN expression","volume":"7","author":"Bidkhori","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.actbio.2018.06.034_b0220","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/aps.2015.152","article-title":"Physcion 8-O-beta-glucopyranoside induces mitochondria-dependent apoptosis of human oral squamous cell carcinoma cells via suppressing survivin expression","volume":"37","author":"Liu","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.actbio.2018.06.034_b0225","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3892\/mmr.2016.5345","article-title":"Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K\/Akt-dependent signaling pathway in reperfusion injury","volume":"14","author":"Cheng","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.actbio.2018.06.034_b0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038770","article-title":"EGFR inhibition in glioma cells modulates Rho signaling to inhibit cell motility and invasion and cooperates with temozolomide to reduce cell growth","volume":"7","author":"Ramis","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.actbio.2018.06.034_b0235","doi-asserted-by":"crossref","first-page":"8690","DOI":"10.1158\/0008-5472.CAN-05-1208","article-title":"Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function","volume":"65","author":"Patel","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2018.06.034_b0240","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/nature05355","article-title":"Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis","volume":"444","author":"Noguera-Troise","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2018.06.034_b0245","doi-asserted-by":"crossref","first-page":"6557","DOI":"10.1038\/sj.onc.1206813","article-title":"Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels","volume":"22","author":"Fonsatti","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.actbio.2018.06.034_b0250","first-page":"469","article-title":"Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis","volume":"39","author":"Shibuya","year":"2006","journal-title":"J. Biochem. Mol. Biol."},{"key":"10.1016\/j.actbio.2018.06.034_b0255","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/dvdy.21392","article-title":"Developmental expression of LC3alpha and beta: absence of fibronectin or autophagy phenotype in LC3beta knockout mice","volume":"237","author":"Cann","year":"2008","journal-title":"Dev. Dynam."},{"issue":"Suppl. 4","key":"10.1016\/j.actbio.2018.06.034_b0260","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0169-5002(01)00386-5","article-title":"Angiogenesis and antiangiogenic agents in non-small cell lung cancer","volume":"34","author":"Galligioni","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1016\/j.actbio.2018.06.034_b0265","article-title":"CD31 expression determines redox status and chemoresistance in human angiosarcomas","author":"Venkataramani","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2018.06.034_b0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006539","article-title":"Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy","volume":"4","author":"Cerniglia","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.actbio.2018.06.034_b0275","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/iju.12231","article-title":"Microvessel area of immature vessels is a prognostic factor in renal cell carcinoma","volume":"21","author":"Sato","year":"2014","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.actbio.2018.06.034_b0280","doi-asserted-by":"crossref","first-page":"52923","DOI":"10.18632\/oncotarget.17629","article-title":"Effect and mechanism of inhibition of PI3K\/Akt\/mTOR signal pathway on chronic neuropathic pain and spinal microglia in a rat model of chronic constriction injury","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.actbio.2018.06.034_b0285","doi-asserted-by":"crossref","first-page":"13738","DOI":"10.1038\/s41598-017-14221-2","article-title":"A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery","volume":"7","author":"Wolfram","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2018.06.034_b0290","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0378-5173(03)00132-7","article-title":"A PEGylated dendritic nanoparticulate carrier of fluorouracil","volume":"257","author":"Bhadra","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2018.06.034_b0295","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.biocel.2017.10.005","article-title":"Aptamer-targeted delivery of Bcl-xL shRNA using alkyl modified PAMAM dendrimers into lung cancer cells","volume":"92","author":"Ayatollahi","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.actbio.2018.06.034_b0300","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.drudis.2014.12.012","article-title":"Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery","volume":"20","author":"Kesharwani","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.actbio.2018.06.034_b0305","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1021\/bc00023a012","article-title":"Polyamidoamine cascade polymers mediate efficient transfection of cells in culture","volume":"4","author":"Haensler","year":"1993","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.actbio.2018.06.034_b0310","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.micinf.2015.05.006","article-title":"Enigma of HIV-1 latent infection in astrocytes: an in-vitro study using protein kinase C agonist as a latency reversing agent","volume":"17","author":"Chauhan","year":"2015","journal-title":"Microbes Infect."},{"key":"10.1016\/j.actbio.2018.06.034_b0315","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.actbio.2008.09.009","article-title":"Characterization of a multifunctional PEG-based gene delivery system containing nuclear localization signals and endosomal escape peptides","volume":"5","author":"Moore","year":"2009","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2018.06.034_b0320","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.4161\/auto.36259","article-title":"How to teach an old dog new tricks: autophagy-independent action of chloroquine on the tumor vasculature","volume":"10","author":"Maes","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.actbio.2018.06.034_b0325","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.lungcan.2007.11.011","article-title":"The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures","volume":"61","author":"Fan","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.actbio.2018.06.034_b0330","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.yexcr.2014.02.026","article-title":"Effect of simvastatin on the resistance to EGFR tyrosine kinase inhibitors in a non-small cell lung cancer with the T790M mutation of EGFR","volume":"323","author":"Hwang","year":"2014","journal-title":"Experiment. Cell Res."},{"key":"10.1016\/j.actbio.2018.06.034_b0335","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.canlet.2017.06.035","article-title":"Tumor vessel normalization by the PI3K inhibitor HS-173 enhances drug delivery","volume":"403","author":"Kim","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.actbio.2018.06.034_b0340","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3816\/CLC.2006.n.021","article-title":"Pharmacodynamic separation of epidermal growth factor receptor tyrosine kinase inhibitors and chemotherapy in non-small-cell lung cancer","volume":"7","author":"Davies","year":"2006","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.actbio.2018.06.034_b0345","first-page":"95","article-title":"Induction of survivin inhibition, G(2)\/M cell cycle arrest and autophagic on cell death in human malignant glioblastoma cells","volume":"58","author":"Tang","year":"2015","journal-title":"Chin. J. Physiol."},{"key":"10.1016\/j.actbio.2018.06.034_b0350","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.febslet.2012.01.050","article-title":"MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin","volume":"586","author":"Bian","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.actbio.2018.06.034_b0355","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41598-017-00517-w","article-title":"Rheumatoid arthritis fibroblast-like synoviocyte suppression mediated by PTEN Involves survivin gene silencing","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2018.06.034_b0360","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.12659\/MSM.898558","article-title":"Anticancer effects of paris saponins by apoptosis and PI3K\/AKT pathway in gefitinib-resistant non-small cell lung cancer","volume":"22","author":"Zhu","year":"2016","journal-title":"Med. Sci. Monitor"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706118303805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706118303805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:08:52Z","timestamp":1761671332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706118303805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":72,"alternative-id":["S1742706118303805"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2018.06.034","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib\/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2018.06.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}